Shire agrees to FDA request for more trials of ADHD medicine in children

LONDON (Reuters) - London-listed drugmaker Shire PLC said it had agreed to a request from the U.S. regulator to test the use of its amphetamine-based drug Vyvanse in preschool children aged four and five with hyperactivity. The FDA, the U.S. regulator ...



from Meta Search Alerts http://ift.tt/TR8Hho

via IFTTT